About
Technology
Issues
FAQ
Links
Official Page
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.